Who Are We?
WHAT ARE WE DOING
About Us
Umayana® Biotechnology is a science-driven regenerative biotechnology company developing innovative medical technologies for the protection, regeneration, and restoration of skin and mucosal tissues.
Murnia® is the registered brand of Umayana® Biotechnology, built upon the company’s patented platform technology. Our solutions are designed to support oncology supportive care, advanced wound management, sensitive skin health, and veterinary care through safe, bio-based, and clinically validated formulations.
With decades of combined experience in biotechnology, medical devices, pharmaceutical development, clinical research, and consumer healthcare, the Umayana® team transforms scientific innovation into practical healthcare solutions that improve patients’ quality of life.
Working closely with physicians, hospitals, universities, and research partners, we continue to develop next-generation regenerative technologies that address significant unmet clinical needs while remaining accessible, sustainable, and globally scalable.
At Umayana®, we believe that innovation creates its greatest value when it reaches patients. Our mission is to develop scientifically validated healthcare technologies that help people heal better, recover faster, and maintain healthier lives.
Patented Molecular Compound
A patented molecular compound serves as the core of every Murnia® product, supporting protection and tissue regeneration through a unique science-based approach for effective results.
Designed for Sensitive & Clinical Use
Murnia® formulations contain no toxic, allergenic, or petroleum-based ingredients and are developed to ensure safe use, even for sensitive and immunocompromised patients.
Ease of Use
The products are simple to use, require no additional intervention, are easy to tolerate, and are designed to deliver a comfortable and safe overall experience without causing any side effects.
User Satisfaction
Based on research findings, user feedback on our products has been consistently positive, reflecting overall satisfaction and trust in their performance and effectiveness.
Founder
With more than two decades of experience spanning biotechnology, pharmaceuticals, medical devices and innovation management, Hülya Dağöttüren has led the development of Umayana’s patented regenerative biotechnology platform from laboratory research to clinical application.
Under her leadership, Umayana continues to build strategic collaborations with physicians, universities, hospitals and international innovation ecosystems to accelerate the global adoption of regenerative healthcare technologies.
Our Mission
To develop patented regenerative healthcare technologies that protect, regenerate and restore skin and mucosal tissues while improving patient outcomes and making advanced care more accessible worldwide.
Our Vision
To become a globally trusted biotechnology company pioneering innovative and sustainable regenerative healthcare technologies.
To get more information about our products…
Visit our Products Page or F.A.Q Page.